结直肠癌中的HER2向治疗:综合性综述
Yeliz Benli1, Helin Arıkan1, Özge Akbulut-Çalışkan2
1Department of Molecular Biology and Genetics, Faculty of Science and Letters, Başkent University, 06790, Ankara, Turkey.
概括
人类表皮生长因子受体2 (HER2) 是转移性结直肠癌 (mCRC) 的2-4%的治疗点. 抗HER2疗法在耐火性mCRC病例中显示出有效性和良好的安全性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因,其特点是显著的异质性.
- 人类表皮生长因子受体2 (HER2) 原型瘤基因放大/过度表达驱动CRCs的一个子集的增殖和瘤发生.
- 在转移性CRC (mCRC) 的2-4%中发现了HER2变异,并且与针对表皮生长因子受体 (EGFR) 向治疗的耐药性有关.
研究的目的:
- 审查目前对结直肠癌中抗HER2疗法的管理.
- 专注于最近的进展以及HER2在mCRC中的预后和预测价值.
- 突出HER2作为一个潜在的治疗点在特定的mCRC群体.
主要方法:
- 关于抗HER2治疗CRC的最新进展的文献综述.
- 在mCRC中分析HER2的预后和预测意义.
- 对抗HER2药物的疗效和安全性的评估.
主要成果:
- 在2~4%的mCRC患者中,HER2过度表达/放大发生.
- 抗HER2疗法显示出高疗效和无毒性,特别是在耐化学反应环境中.
- HER2状态对于指导治疗决策和预测反应至关重要.
结论:
- 针对HER2是对mCRC患者的一个子集的可行策略.
- 评估HER2水平对于优化mCRC治疗选择至关重要.
- 抗HER2疗法提供了一个有前途的治疗途径,在先进的CRC中具有良好的结果.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.1K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...